Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
A postdoctoral position is available in Dr Ivan Ahel’s group at the Sir William Dunn School of Pathology, University of Oxford to study ADP-ribosylation signalling and its role in genome stability
-
A postdoctoral position is available in Dr Ivan Ahel’s group at the Sir William Dunn School of Pathology, University of Oxford to study the interplay of ADP-ribosylation and ubiquitylation
-
Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford. As a post holder, you will manage the BioLig production team, through planning
-
a focus in a research area that aligns with and complements the aims of the Department of Oncology and other cancer research groups at the University of Oxford. Two of the posts will be dedicated
-
assistant if required. Applicants should have a relevant PhD, significant postdoctoral experience, a clear, feasible and relevant research plan and be an author of high impact papers. The position is full
-
University of Oxford, the Swedish University of Agricultural Sciences (SLU) and Wageningen University & Research (WUR), the TABLE network has since expanded to include la Universidad de los Andes (Colombia
-
below. The closing date for applications is 12.00 midday, Friday, 26 April 2024. Interviews will be held as soon as possible thereafter. The University of Oxford and The Department of Chemistry are Silver
-
. The University of Oxford and The Department of Chemistry are Silver Athena SWAN holders. Applications are particularly welcome from women and black and ethnic minority candidates, who are under-represented in
-
that are precisely matched to the patients most likely to benefit. The post is based in the Big Data Institute, University of Oxford. The post is for a fixed term (funded for 4 years) and is full-time although
-
We have an exciting opportunity for a Postdoctoral Researcher who wants to drive research into novel cancer therapeutics with the potential to impact human health, to join the group of Dr Joseph